Hepatobiliary Oncology
Research activity includes resectable hepatocellular carcinoma, with interest in perioperative therapy and immunotherapy approaches centered on durvalumab and tremelimumab.
- Hepatocellular carcinoma
- Resectable liver cancer
- Checkpoint inhibitor combinations
The clinical focus is on treatment strategies for surgically manageable liver malignancy within a multi-site research network.
Gynecologic Oncology
Clinical research also addresses cervical cancer, particularly node-negative disease in FIGO stage IB2, with attention to treatment approaches that integrate neoadjuvant chemotherapy and fertility-sparing surgery.
- Cervical cancer
- FIGO stage IB2 disease
- Fertility preservation
The studies reflect a therapeutic interest in conserving reproductive potential while managing localized gynecologic malignancy.
